References
- Bonnez W, Lattimer G, Mohanraj NA. Actinomycosis naeslundii as an agent of pelvic actinomycosis in the presence of an intrauterine device. J Clin Microbiol 1985; 21: 273–5
- Handerson S. Pelvic actinomycosis associated with an intrauterine device. Obstet Gynecol 1973; 41: 726–32
- Marty H, Wust J. Disseminated actinomycosis caused by Acinomyces mayerii. Infection 1989; 17: 154–5
- Persson E. Genital actinomycosis and Actinomyces israelii in the female genital tract. Adv Contracept 1987; 3: 115–123
- Fass RJ, Scholan JF, Hodges GR. Clindamycin in treatment of serious anaerobic infections. Ann Inter Med 1973; 78: 853–9
- Lerner P. Susceptibility of pathogenic actinomycosis to antimicrobial compounds. Antimicrob Agents Chemother 1974; 5: 302–9
- Martin M. The use of oral amoxicillin for the treatment of actinomycosis. Br Dent J 1984; 156: 252–4
- Martin MV. Antibiotic treatment of cervicofacial actinomycosis for patients allergic to penicillin: a clinical and in vitro study. Br J Oral Maxillofac Surg 1985; 23: 428–35
- Schleck W, Gelfand M, Alper B, et al. Medical management of visceral actinomycosis. South Med J 1983; 76: 921–2
- Shore K, Pottumarthy S, Moris AJ. Susceptibility of anaerobic bacteria in Auckland 1991–1996. N Z Med J 1999; 112: 424–6
- Skoutelis A, Petrochilos J, Bassaris H. Successful treatment of thoracic actinomycosis with ceftriaxone. Clin Infect Dis 1994; 19: 161–2